Helping the injured since 1983

Contact us at (713) 352-7071 to schedule a FREE consultation today.

Get Help NOW!

Blog

Possible treatments for individuals with gynecomastia

Posted on Thursday, June 9th, 2016 at 4:25 pm by Williams Hart   

When male individuals experience hormonal imbalances such that their estrogen level increases relative to their androgen hormone, their breasts may become unusually large. Though some cases of gynecomastia improve during puberty after several months, other men with this condition may consider the following treatments if the problem persists.

  • Patients may want to lessen breast volume by undergoing selective estrogen receptor modulator (SERM) therapy

  • Patients may be advised to take medications like Danazol or Clomiphene

  • Older patients, or those who have abnormal hormone levels, may be advised to undergo testosterone replacement

  • Individuals who have serious cases of gynecomastia are usually required to undergo mammoplasty surgery to reduce their breast size

Although men who develop gynecomastia only have a small chance of contracting breast cancer, they are likely to suffer from psychological problems from having unusually large breasts.

Gynecomastia, unfortunately, is one of the dangerous side effects of taking Risperdal for the treatment of conditions such as schizophrenia, autism, and bipolar disorder. If you think that taking Risperdal has caused your gynecomastia, the talented legal team at Williams Hart may be able to represent you. Call our offices at (713) 352-7071 to learn more about your legal options and discuss your situation.


Jury ruled J&J failed to warn about Risperdal’s gynecomastia risk

Posted on Thursday, March 26th, 2015 at 12:50 pm by Williams Hart   

In a 10 out of 12 vote, a jury in Philadelphia asserted that Johnson & Johnson’s (J&J) Janssen Pharmaceuticals failed to warn patients and prescribers about the possible risk of gynecomastia among young males taking the atypical antipsychotic drug Risperdal, Market Watch reported on Friday, March 20.

The jury decision came after a three week trial over a case filed by a 19-year-old plaintiff who claimed that taking the antipsychotic drug from age six to ten led him to develop breasts, a condition know as gynecomastia. The company, however, concealed the risk from prescribers. According to the report, the patient stopped using the drug in 2006, the year when the U.S. Food and Drug Administration granted Risperdal approval for limited use in children and adolescents.

Since its FDA approval in 1993 and prior to 2006, Risperdal was only allowed for use in adults and was prescribed off-label to young patients.

If you believe Risperdal has caused your loved one to suffer from any adverse health condition, a lawyer at Williams Hart might be able to represent you in seeking justice and compensation. Call us at (713) 352-7071 to learn more about taking legal action today.


Treating Risperdal-induced gynecomastia

Posted on Friday, February 6th, 2015 at 12:23 pm by Williams Hart   

Gynecomastia, or the abnormal growth of breast tissue among adolescent males, has been linked to the use of atypical anti-psychotic drug Risperdal. Over many years, more and more have been filing legal claims against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, saying that the companies failed to warn physicians and consumers about the risk of gynecomastia.

Because Risperdal-induced gynecomastia could be a result of the drug’s adverse effect on the pituitary gland, doctors may suggest treating the abnormality in the pituitary gland through medications or surgery. Furthermore, doctors may also suggest one of these surgical options in removing excess breast tissue:

  • Mastectomy – The removal of the breast tissue and the breast gland itself
  • Liposuction – This involves the removal of the breast tissues, but not the breast gland

Having a Risperdal-induced gynecomastia is financially costly and medically risky, and could have been prevented if the drug manufacturers have not failed to warn physicians about its dangers. If your loved one has suffered due to Risperdal, our legal team at Williams Hart might be of help. Call us at (713) 352-7071 for advice on how to take legal action.


A closer look at gynecomastia and its causes

Posted on Wednesday, March 5th, 2014 at 1:22 pm by Williams Hart   

Gynecomastia, or the enlargement of breast tissues among males, is a medical condition caused by the imbalance of the hormones estrogen and testosterone. This illness may affect one or both breasts, and may occur upon birth or during the adolescent period.

Certain underlying medical conditions have been associated with gynecomastia, such as liver cirrhosis, kidney failure, and hyperthyroidism. Several cases of gynecomastia, however, have been found to be a result of using Risperdal – an antipsychotic drug being marketed as safe and effective for pediatric use.

Treatment of gynecomastia can involve invasive and financially costly procedures, such as mastectomy and liposuction. If you believe using Risperdal has caused your child to suffer from gynecomastia, you have the right to explore your options for filing a lawsuit against its maker. Our lawyers at Williams Hart know how to legally assist victims in their fight for justice and financial compensation. Call us at (713) 352-7071 to determine the possibility of taking legal action.


Williams Hart Representing Risperdal Victims

Posted on Monday, February 3rd, 2014 at 1:46 pm by Williams Hart   

Risperdal, an anti-psychotic drug developed in the late 1980’s, is most commonly prescribed to patients with schizophrenia, bipolar disorder, and autism. The Food and Drug Administration (FDA) first approved Risperdal to treat behavioral symptoms in 1994. Since its market release, people around the world have relied on Risperdal to regulate behavioral and emotional inconsistencies.

Unfortunately, a significant percentage of people who have used Risperdal have suffered from adverse effects like gynecomastia, hyperglycemia, Tardive Dyskenisia, pancreatitis, and multiple other conditions. Recent research has revealed that Johnson & Johnson, Risperdal’s manufacturer, might have released the drug to consumers while knowing of its harmful effects.

The attorneys at Williams Hart are now representing people who have suffered because of Risperdal use. If you, or someone you know, has suffered from the dangerous effects of this medication, call (713) 352-7071 to discuss your legal options with an experienced attorney.

Wh-emblem
Have you or a loved one been injured in an accident?

Contact us today at (713) 352-7071 to get a free, confidential case evaluation.